The current earnings season brought some harsh weather to shareholders in Steris (NYSE: STE). The healthcare company unveiled its latest set of quarterly figures on Wednesday and was punished for it, as the stock traded down by almost 12% over the trading week, according to data from S&P Global Market Intelligence. For the third quarter of Steris' fiscal 2023, the company had $1.22 billion in revenue.